Centiva Capital, LP Biolife Solutions Inc Transaction History
Centiva Capital, LP
- $3.13 Billion
- Q1 2025
A detailed history of Centiva Capital, LP transactions in Biolife Solutions Inc stock. As of the latest transaction made, Centiva Capital, LP holds 12,283 shares of BLFS stock, worth $270,103. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,283Holding current value
$270,103% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BLFS
# of Institutions
202Shares Held
48.8MCall Options Held
2.5KPut Options Held
182K-
Casdin Capital, LLC New York, NY8.71MShares$191 Million23.27% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$121 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.55MShares$78.1 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$61.7 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.53MShares$33.7 Million0.21% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $939M
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...